Case Report
Published on 26 Oct 2023
First use of 18F-FDG PET in TEMPI syndrome: can it be used for treatment assessment? A case report
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1273967
- 1,032 views
Type at least 3 characters
148 articles
Articles
Review
Published on 25 Oct 2023
Emerging theragnostic radionuclide applications for hepatocellular carcinoma
in Radionuclide Therapy
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1210982
- 1,923 views
- 1 citation
Hypothesis and Theory
Published on 13 Oct 2023
Radiopharmaceutical administration practices—Are they best practice?
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1244660
- 2,583 views
- 1 citation
Mini Review
Published on 09 Oct 2023
Mini review of first-in-human integrin αvβ6 PET tracers
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1271208
- 2,463 views
- 1 citation
Brief Research Report
Published on 04 Oct 2023
[18F]NaF PET/CT imaging of response to single fraction SABR to bone metastases from breast cancer
in PET and SPECT
![[18F]NaF PET/CT imaging of response to single fraction SABR to bone metastases from breast cancer](https://www.frontiersin.org/files/myhome article library/1197397/1197397_Thumb_400.jpg)
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1197397
- 1,081 views
- 1 citation
Review
Published on 21 Sep 2023
Evaluation of deep space exploration risks and mitigations against radiation and microgravity
in Dosimetry and Radiation Safety
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1225034
- 5,603 views
- 5 citations
Original Research
Published on 20 Sep 2023
Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1184309
- 1,560 views
Original Research
Published on 14 Sep 2023
Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
in Radiomics and Artificial Intelligence
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1234853
- 1,591 views
- 2 citations
Original Research
Published on 12 Sep 2023
Post-acquisition standardization of positron emission tomography images
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1210931
- 805 views
Perspective
Published on 05 Sep 2023
To tell or not to tell … the patient about potential harm
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1258960
- 1,257 views
Case Report
Published on 24 Aug 2023
Case report: 18F-FDG PET-CT findings in Bickerstaff encephalitis before and after treatment
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1235173
- 987 views
Review
Published on 04 Aug 2023
Theranostics in breast cancer
in Radionuclide Therapy
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1236565
- 3,801 views
- 3 citations
Case Report
Published on 03 Aug 2023
Case report: Peptide receptor radioligand therapy in metastatic pediatric neuroendocrine tumors
in Radionuclide Therapy
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1193880
- 965 views
- 1 citation
Opinion
Published on 31 Jul 2023
Critique and discussion of “Multicenter evaluation of frequency and impact of activity infiltration in PET imaging, including microscale modeling of skin-absorbed dose”
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1240162
- 742 views
- 1 citation
Original Research
Published on 28 Jul 2023
A systematic evaluation of five different image-derived input functions for the clinical implementation of 18F-NaF bone PET/CT in patients with chronic kidney disease–mineral and bone disorder
in PET and SPECT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1235800
- 1,013 views
Review
Published on 27 Jul 2023
Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular disease
in Radionuclide Therapy
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1224905
- 1,268 views